Biogen Community Statement

The following statement has been shared with fara regarding the status of reimbursed access to SKYCLARYS

Previous
Previous

Hearing & Brain Research Study Invitation

Next
Next

Lexeo Therapeutics Regulatory Update and Registrational Trial Design for LX2006